US Stock MarketDetailed Quotes

PTC Therapeutics (PTCT)

Watchlist
  • 68.230
  • -0.360-0.52%
Close Apr 24 16:00 ET
  • 68.230
  • 0.0000.00%
Post 17:17 ET
5.66BMarket Cap8.77P/E (TTM)

PTC Therapeutics (PTCT) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
760.42%711.2M
-14.23%-34.27M
13.89%-66.3M
18.36%-58.33M
1,129.64%870.1M
32.02%-107.69M
70.08%-30M
-430.28%-76.99M
-406.04%-71.45M
339.94%70.76M
Net income from continuing operations
287.90%682.64M
-104.85%-134.97M
114.90%15.9M
34.61%-64.85M
1,046.28%866.56M
42.02%-363.3M
57.71%-65.89M
19.79%-106.65M
50.13%-99.18M
34.10%-91.58M
Operating gains losses
287.65%10.75M
157.17%5.69M
-93.11%45K
-2.64%2.69M
186.35%2.33M
-114.80%-5.73M
-128.94%-9.96M
-96.10%653K
216.99%2.76M
108.08%813K
Depreciation and amortization
-48.70%38.82M
90.75%12.9M
71.28%11.11M
8.05%7.58M
-86.96%7.22M
-68.02%75.66M
-91.62%6.76M
-89.55%6.49M
-86.24%7.02M
29.35%55.4M
Deferred tax
99.99%-3K
100.00%1K
-33.33%-4K
-200.00%-2K
300.00%2K
-19.14%-55.91M
-1,505.13%-55.91M
-50.00%-3K
100.00%2K
75.00%-1K
Other non cash items
73.43%-20.98M
80.54%-22.19M
-544.01%-11.78M
-103.09%-311K
-50.45%13.29M
24.54%-78.98M
-2,306.40%-114.03M
-241.45%-1.83M
108.20%10.05M
134.37%26.82M
Change In working capital
-146.69%-47.88M
149.09%91.11M
-829.68%-84.88M
-49.58%-16.72M
-157.09%-37.4M
2,661.65%102.54M
144.28%36.58M
54.97%11.63M
-134.51%-11.18M
69.21%65.51M
-Change in receivables
-686.09%-10.15M
-45.50%22.21M
16.13%-6.47M
167.41%21.9M
-20.99%-47.79M
212.54%1.73M
388.27%40.76M
-194.89%-7.72M
-67.76%8.19M
9.04%-39.5M
-Change in inventory
-974.37%-53.9M
-341.56%-26.78M
-496.46%-18.53M
-456.92%-10.78M
1,725.83%2.19M
175.33%6.16M
86.70%11.09M
28.20%-3.11M
62.65%-1.94M
102.60%120K
-Change in prepaid assets
-130.73%-34.18M
-369.53%-21.81M
-89.21%649K
-15.58%4.02M
-116.21%-17.04M
379.66%111.22M
95.53%-4.64M
188.13%6.01M
-62.04%4.76M
80.10%105.1M
-Change in payables and accrued expense
315.30%71.74M
428.47%108.08M
-336.29%-43.21M
12.58%-11.64M
443.33%18.5M
-168.92%-33.32M
-515.89%-32.91M
128.65%18.29M
-1,124.75%-13.31M
-116.08%-5.39M
-Change in other current liabilities
-247.05%-17.4M
-45.05%9.1M
-398.48%-9.18M
-89.97%-16.86M
-107.65%-458K
612.79%11.83M
3,105.99%16.56M
-241.72%-1.84M
-1,051.34%-8.88M
250.05%5.98M
-Change in other working capital
-181.31%-4M
-94.75%300K
---8.14M
---3.36M
998.88%7.2M
994.00%4.92M
1,451.77%5.72M
--0
--0
29.55%-801K
Cash from discontinued investing activities
Operating cash flow
760.42%711.2M
-14.23%-34.27M
13.89%-66.3M
18.36%-58.33M
1,129.64%870.1M
32.02%-107.69M
70.08%-30M
-430.28%-76.99M
-406.04%-71.45M
339.94%70.76M
Investing cash flow
Cash flow from continuing investing activities
-2,050.98%-861.98M
-87.30%34.01M
-578.67%-289.62M
-540.15%-422.01M
-60.41%-184.36M
125.00%44.18M
383.54%267.71M
-44.19%-42.68M
-177.55%-65.92M
-296.71%-114.93M
Net PPE purchase and sale
-140.78%-8.79M
36.98%-2.37M
-583.53%-3.45M
-103.72%-1.32M
82.75%-1.65M
175.79%21.55M
32.32%-3.77M
92.07%-504K
667.06%35.41M
6.64%-9.59M
Net intangibles purchase and sale
-329.76%-291.15M
-1,179.01%-34.92M
-2,364.89%-252.75M
---2.68M
98.52%-808K
26.51%-67.75M
88.08%-2.73M
55.12%-10.25M
--0
-63.98%-54.76M
Net investment purchase and sale
-842.63%-562.04M
-42.60%71.3M
-4.73%-33.43M
-312.50%-418.02M
-259.62%-181.9M
-6.25%-59.63M
288.32%124.21M
-8,083.85%-31.92M
-2,168.04%-101.34M
-444.18%-50.58M
Net other investing changes
----
----
----
----
----
--150M
----
----
----
----
Cash from discontinued investing activities
Investing cash flow
-2,050.98%-861.98M
-87.30%34.01M
-578.67%-289.62M
-540.15%-422.01M
-60.41%-184.36M
125.00%44.18M
383.54%267.71M
-44.19%-42.68M
-177.55%-65.92M
-296.71%-114.93M
Financing cash flow
Cash flow from continuing financing activities
29.40%331.09M
1,042.78%302.5M
186.34%15.22M
-98.39%3.96M
1,642.59%9.41M
-60.42%255.87M
-95.73%26.47M
-624.46%-17.63M
1,235.22%246.48M
-86.81%540K
Net issuance payments of debt
-8.12%-1.61M
--0
---1.61M
--0
--0
99.51%-1.49M
--0
--0
--0
-8.05%-1.49M
Net common stock issuance
----
----
----
----
----
--0
----
----
----
----
Proceeds from stock option exercised by employees
193.35%99.05M
136.12%62.5M
2,837.17%16.83M
-15.54%3.96M
675.91%15.75M
12.57%33.76M
994.75%26.47M
-83.37%573K
-74.61%4.69M
-64.10%2.03M
Net other financing activities
4.50%233.66M
--240M
--0
--0
---6.34M
-75.64%223.59M
--0
-21,311.76%-18.2M
----
----
Cash from discontinued financing activities
Financing cash flow
29.40%331.09M
1,042.78%302.5M
186.34%15.22M
-98.39%3.96M
1,642.59%9.41M
-60.42%255.87M
-95.73%26.47M
-624.46%-17.63M
1,235.22%246.48M
-86.81%540K
Net cash flow
Beginning cash position
30.32%795.32M
27.14%686.3M
54.53%1.03B
164.93%1.5B
30.32%795.32M
106.23%610.28M
197.55%539.79M
197.80%668.54M
141.71%564.62M
106.23%610.28M
Current changes in cash
-6.27%180.31M
14.41%302.24M
-148.16%-340.71M
-536.62%-476.38M
1,693.25%695.15M
-38.20%192.36M
-37.95%264.18M
-236.88%-137.29M
662.05%109.11M
19.75%-43.63M
Effect of exchange rate changes
409.93%22.71M
213.20%9.8M
-170.99%-6.06M
361.96%13.59M
365.67%5.39M
-335.32%-7.33M
-379.58%-8.65M
466.30%8.54M
-150.29%-5.19M
74.51%-2.03M
End cash Position
25.53%998.33M
25.53%998.33M
27.14%686.3M
54.53%1.03B
164.93%1.5B
30.32%795.32M
30.32%795.32M
197.55%539.79M
197.80%668.54M
141.71%564.62M
Free cash flow
326.00%411.18M
-96.06%-71.56M
-267.44%-322.5M
2.73%-62.33M
13,434.65%867.57M
34.80%-181.94M
71.65%-36.5M
-100.73%-87.77M
-91.83%-64.08M
108.76%6.41M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 760.42%711.2M-14.23%-34.27M13.89%-66.3M18.36%-58.33M1,129.64%870.1M32.02%-107.69M70.08%-30M-430.28%-76.99M-406.04%-71.45M339.94%70.76M
Net income from continuing operations 287.90%682.64M-104.85%-134.97M114.90%15.9M34.61%-64.85M1,046.28%866.56M42.02%-363.3M57.71%-65.89M19.79%-106.65M50.13%-99.18M34.10%-91.58M
Operating gains losses 287.65%10.75M157.17%5.69M-93.11%45K-2.64%2.69M186.35%2.33M-114.80%-5.73M-128.94%-9.96M-96.10%653K216.99%2.76M108.08%813K
Depreciation and amortization -48.70%38.82M90.75%12.9M71.28%11.11M8.05%7.58M-86.96%7.22M-68.02%75.66M-91.62%6.76M-89.55%6.49M-86.24%7.02M29.35%55.4M
Deferred tax 99.99%-3K100.00%1K-33.33%-4K-200.00%-2K300.00%2K-19.14%-55.91M-1,505.13%-55.91M-50.00%-3K100.00%2K75.00%-1K
Other non cash items 73.43%-20.98M80.54%-22.19M-544.01%-11.78M-103.09%-311K-50.45%13.29M24.54%-78.98M-2,306.40%-114.03M-241.45%-1.83M108.20%10.05M134.37%26.82M
Change In working capital -146.69%-47.88M149.09%91.11M-829.68%-84.88M-49.58%-16.72M-157.09%-37.4M2,661.65%102.54M144.28%36.58M54.97%11.63M-134.51%-11.18M69.21%65.51M
-Change in receivables -686.09%-10.15M-45.50%22.21M16.13%-6.47M167.41%21.9M-20.99%-47.79M212.54%1.73M388.27%40.76M-194.89%-7.72M-67.76%8.19M9.04%-39.5M
-Change in inventory -974.37%-53.9M-341.56%-26.78M-496.46%-18.53M-456.92%-10.78M1,725.83%2.19M175.33%6.16M86.70%11.09M28.20%-3.11M62.65%-1.94M102.60%120K
-Change in prepaid assets -130.73%-34.18M-369.53%-21.81M-89.21%649K-15.58%4.02M-116.21%-17.04M379.66%111.22M95.53%-4.64M188.13%6.01M-62.04%4.76M80.10%105.1M
-Change in payables and accrued expense 315.30%71.74M428.47%108.08M-336.29%-43.21M12.58%-11.64M443.33%18.5M-168.92%-33.32M-515.89%-32.91M128.65%18.29M-1,124.75%-13.31M-116.08%-5.39M
-Change in other current liabilities -247.05%-17.4M-45.05%9.1M-398.48%-9.18M-89.97%-16.86M-107.65%-458K612.79%11.83M3,105.99%16.56M-241.72%-1.84M-1,051.34%-8.88M250.05%5.98M
-Change in other working capital -181.31%-4M-94.75%300K---8.14M---3.36M998.88%7.2M994.00%4.92M1,451.77%5.72M--0--029.55%-801K
Cash from discontinued investing activities
Operating cash flow 760.42%711.2M-14.23%-34.27M13.89%-66.3M18.36%-58.33M1,129.64%870.1M32.02%-107.69M70.08%-30M-430.28%-76.99M-406.04%-71.45M339.94%70.76M
Investing cash flow
Cash flow from continuing investing activities -2,050.98%-861.98M-87.30%34.01M-578.67%-289.62M-540.15%-422.01M-60.41%-184.36M125.00%44.18M383.54%267.71M-44.19%-42.68M-177.55%-65.92M-296.71%-114.93M
Net PPE purchase and sale -140.78%-8.79M36.98%-2.37M-583.53%-3.45M-103.72%-1.32M82.75%-1.65M175.79%21.55M32.32%-3.77M92.07%-504K667.06%35.41M6.64%-9.59M
Net intangibles purchase and sale -329.76%-291.15M-1,179.01%-34.92M-2,364.89%-252.75M---2.68M98.52%-808K26.51%-67.75M88.08%-2.73M55.12%-10.25M--0-63.98%-54.76M
Net investment purchase and sale -842.63%-562.04M-42.60%71.3M-4.73%-33.43M-312.50%-418.02M-259.62%-181.9M-6.25%-59.63M288.32%124.21M-8,083.85%-31.92M-2,168.04%-101.34M-444.18%-50.58M
Net other investing changes ----------------------150M----------------
Cash from discontinued investing activities
Investing cash flow -2,050.98%-861.98M-87.30%34.01M-578.67%-289.62M-540.15%-422.01M-60.41%-184.36M125.00%44.18M383.54%267.71M-44.19%-42.68M-177.55%-65.92M-296.71%-114.93M
Financing cash flow
Cash flow from continuing financing activities 29.40%331.09M1,042.78%302.5M186.34%15.22M-98.39%3.96M1,642.59%9.41M-60.42%255.87M-95.73%26.47M-624.46%-17.63M1,235.22%246.48M-86.81%540K
Net issuance payments of debt -8.12%-1.61M--0---1.61M--0--099.51%-1.49M--0--0--0-8.05%-1.49M
Net common stock issuance ----------------------0----------------
Proceeds from stock option exercised by employees 193.35%99.05M136.12%62.5M2,837.17%16.83M-15.54%3.96M675.91%15.75M12.57%33.76M994.75%26.47M-83.37%573K-74.61%4.69M-64.10%2.03M
Net other financing activities 4.50%233.66M--240M--0--0---6.34M-75.64%223.59M--0-21,311.76%-18.2M--------
Cash from discontinued financing activities
Financing cash flow 29.40%331.09M1,042.78%302.5M186.34%15.22M-98.39%3.96M1,642.59%9.41M-60.42%255.87M-95.73%26.47M-624.46%-17.63M1,235.22%246.48M-86.81%540K
Net cash flow
Beginning cash position 30.32%795.32M27.14%686.3M54.53%1.03B164.93%1.5B30.32%795.32M106.23%610.28M197.55%539.79M197.80%668.54M141.71%564.62M106.23%610.28M
Current changes in cash -6.27%180.31M14.41%302.24M-148.16%-340.71M-536.62%-476.38M1,693.25%695.15M-38.20%192.36M-37.95%264.18M-236.88%-137.29M662.05%109.11M19.75%-43.63M
Effect of exchange rate changes 409.93%22.71M213.20%9.8M-170.99%-6.06M361.96%13.59M365.67%5.39M-335.32%-7.33M-379.58%-8.65M466.30%8.54M-150.29%-5.19M74.51%-2.03M
End cash Position 25.53%998.33M25.53%998.33M27.14%686.3M54.53%1.03B164.93%1.5B30.32%795.32M30.32%795.32M197.55%539.79M197.80%668.54M141.71%564.62M
Free cash flow 326.00%411.18M-96.06%-71.56M-267.44%-322.5M2.73%-62.33M13,434.65%867.57M34.80%-181.94M71.65%-36.5M-100.73%-87.77M-91.83%-64.08M108.76%6.41M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
Signs of restarting the second round of US-Iran talks have emerged. According to reports, Iran's foreign minister arrived in Pakistan on Fri Show More